Abstract:To gather impressions from patients/caregivers/advocates with acute leukemia regarding preferences for accessing scientific information, the value of patients as authors of scientific publications, and the format of plain language summaries (PLS). In addition, use of an asynchronous virtual advisory board (VAB) was piloted with this group. We conducted a 14-day asynchronous VAB (using SkyBoard) with six patients/caregivers/advocates. Patients/caregivers/advocates were identified in collaboration with the Acute Leukemia Advocates Network. Asynchronous VABs are an alternative to in-person advisory boards/synchronous VABs (video conferencing), enabling patients/caregivers/advocates to interact with VABs/each other in their own time. Platform features used to gather data included surveys, online forums, and content reviews of PLS. An international group of patients/caregivers/advocates were actively engaged in the VAB at convenient times for them. Privacy settings allowed for partial anonymity (personal details not shown) while enabling interactions with peers/facilitators. Key learnings included: patients/caregivers/advocates trust advocacy organizations to deliver scientific information; patients/caregivers/advocates often feel overwhelmed by the volume of scientific information available/seek a central hub for information; patients/caregivers/advocates are aware of PLS; advocates are well suited to co-author scientific publications/disseminate PLS; and PLS should include varying levels of detail to satisfy all patients/caregivers/advocates needs. Video is also the most preferred alternative format to infographic PLS. Patients/caregivers/advocates welcomed the opportunity to discuss the communication of scientific information. The asynchronous VAB was an effective and efficient format for individuals to interact, assess materials and engage in virtual discussion. Feedback resulted in the development of a video abstract PLS for an oncology congress. Asynchronous VABs offer advantages to in-person advisory boards, including flexibility, convenience, and low cost. Scientific communication platforms (SCPs) support consistent and accurate communication around pharmaceutical products. As development requires significant investment of budget and time, our aim was to understand SCP perception and use. An 18-item, online survey was developed to gather insights into company employees' awareness and use of SCPs and emailed to >900 recipients across functions. The survey was active from 1 to 18 November 2021. Of 115 respondents, 60% were in a medical role and 52% were local employees. 46 (40%) were aware of SCPs. A higher proportion (52%) of those in a medical role were aware of SCPs. More respondents in a global role (23/53 [43%]) were aware of SCPs than those in a local role (22/60 [37%]). Of respondents aware of SCPs, most (79%) knew where to find or start looking for them, or who to ask to locate them. This was consistent for global and local employees. The majority (67%) of respondents who were aware of SCPs were also aware that they were regularly updated. Of respondents aware of SCPs, 20 (43%) reported regular or occasional use. Among 40 respondents who had used SCPs, 75% and 72.5% highly rated the usefulness and quality/accuracy of SCPs, respectively. Most frequent SCP use was in educational materials (23/40 [58%]), congress materials (14 [35%]), and publication planning/development (12 [30%]). Awareness of SCPs was more common among employees in global roles and in the medical function. Our findings highlight the need for frequent communication and/or education around SCPs to cross-functional and regional colleagues to increase uptake and engagement. Journals are publishing peer-reviewed podcasts summarizing the latest findings presented at scientific congresses. However, they are not in plain language to appeal to broader audiences, including patients/patient advocates. Our objective was to create a process for developing plain language podcasts to increase accessibility to relevant data from congresses for patients and HCPs. We used a collaborative process to publish a peer-reviewed, citable, plain language podcast (Figure 1). The peer-reviewed plain language podcast of the European Society for Medical Oncology 2021 congress was accepted for publication in Oncology and Therapy in 2022. The podcast (and transcript/glossary) is available on PubMed, Google Podcasts, and Spotify. It focuses on topics such as patient involvement at congresses, as well as data in bladder/kidney cancer. We successfully published a peer-reviewed, citeable, plain language podcast. We believe this process will facilitate the development of further podcasts, increasing the accessibility of data presented at scientific congresses, while empowering patients and HCPs to engage with research. Healthcare systems contribute to approximately 5% of national carbon footprints, with up to -Abstract Truncated-

Oral communication abstracts

Poster abstracts

Thesis awards

Master 2 award

Head and Neck Surgery Poster Presentations

Abstract 3553: OralDB, A integrative data portal for oral and oropharyngeal cancer omics and clinical research

Abstracts J Vet Dent, Issue 39:2

Brain Embolism‐Induced Injury of Vascular Endothelial Cells and a Novel Vasoprotective Drug

Advances in clinical studies of oral anticoagulation

Clinical Issues — October 2024

Editorial for GPR84 pharmacology

Abstract C079: Investigating the interplay among allostatic load, social determinants of health, and treatment outcomes in chronic myeloid leukemia patients

Original Abstracts from the 18th Annual Meeting of ISMPP

Advancing oral immunology for improving oral health

INCLUDING TOXICOLOGICAL SCIENCES

Meeting abstracts from the 9th International Conference on cGMP: Generators, Effectors and Therapeutic Implications

Oral chemotherapy: rationale and future directions.

Abstracts From the NCCN 2020 Virtual Annual Conference

Modulation of oral bioavailability of anticancer drugs: from mouse to man

Debates in cardiovascular pharmacology and drug discovery: 2022

Abstract A078: Cancer Incidence in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) – The Onco-SOL Ancillary Study